Hydrogenology
Source-linked study record

Application of Molecular Hydrogen as an Antioxidant in Responses to Ventilatory and Ergogenic Adjustments during Incremental Exercise in Humans

Alharbi AAD, Ebine N, Nakae S, Hojo T, Fukuoka Y. · Nutrients. 2021;13(2):459.

HumanOther formsPublished 2021Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Healthy trained young men without cardiac, ventilatory, gas-exchange or musculoskeletal disorders.

Intervention and dose

Four oral capsules/day for three consecutive days containing 1,500 mg/day H₂-rich calcium powder. · The 1,500 mg daily powder dose was reported to contain 2.544 µg H₂/day.

Duration

Three consecutive days per condition; washout details are reported in the linked methods.

Reported result

At rest HCP reduced ventilation, oxygen uptake and carbon-dioxide output and produced higher PCO₂/HCO₃⁻ with lower pH. During exercise ventilation remained lower and local rectus-femoris oxygen extraction changed, while oxygen uptake, carbon-dioxide output, heart rate, lactate/glucose and exercise performance were not improved.

Main limitation

Small male-only physiological study with many correlated endpoints and no demonstrated performance gain. The powder and placebo were ENAGEGATE products and the article describes a patented H₂-rich calcium technique; a separate sponsor role was not stated in the article's accessible declarations. This article and the 2022 single-dose study share ethics approval 18012 and investigators, so participant independence cannot be assumed.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Randomized double-blind placebo-controlled crossover study

Research topic

Exercise and recovery

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Healthy trained young men without cardiac, ventilatory, gas-exchange or musculoskeletal disorders.

Sample

18 men; mean age 21±1 years. Each participant received both interventions.

Duration

Three consecutive days per condition; washout details are reported in the linked methods.

Intervention

Four oral capsules/day for three consecutive days containing 1,500 mg/day H₂-rich calcium powder.

Hydrogen form

Oral H₂-rich calcium powder — not inhaled gas, not hydrogen water and not Brown's gas.

Dose or H₂ specification

The 1,500 mg daily powder dose was reported to contain 2.544 µg H₂/day.

Comparator

Identical capsules containing H₂-depleted calcium powder; crossover order was randomized and blinded.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Resting acid-base and ventilation measures, incremental cycling to exhaustion, pulmonary gas exchange, heart rate, lactate, glucose and local quadriceps oxygenation.

Reported result

At rest HCP reduced ventilation, oxygen uptake and carbon-dioxide output and produced higher PCO₂/HCO₃⁻ with lower pH. During exercise ventilation remained lower and local rectus-femoris oxygen extraction changed, while oxygen uptake, carbon-dioxide output, heart rate, lactate/glucose and exercise performance were not improved.

Extraction completeness

The complete MDPI/PMC article, crossover methods, intervention quantity, rest and exercise tables and commercial product information were checked; null performance and gas-exchange outcomes are included.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Small male-only physiological study with many correlated endpoints and no demonstrated performance gain. The powder and placebo were ENAGEGATE products and the article describes a patented H₂-rich calcium technique; a separate sponsor role was not stated in the article's accessible declarations. This article and the 2022 single-dose study share ethics approval 18012 and investigators, so participant independence cannot be assumed.

Applies directly to

Healthy trained young men under this short product-specific protocol; not evidence of clinical benefit.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 33573133 · DOI: 10.3390/nu13020459

Publisher access

Open-access full article on MDPI and PubMed Central.

Extraction basis

MDPI and PMC full article plus PubMed metadata; full-text and article-status check completed 8 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.